Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
AssigneeNovaremed Limited
InventorEliahu Kaplan
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds, pharmaceutical compositions and methods for treating, immuno-allergical diseases, autoimmune diseases, and organ or tissue rejection following transplantation.
Claims140
A compound represented by the structure of formula I:
- wherein
- the dotted line represents a single or a double bond;
- R1 and R2 are the same or different, and independently of each other represent —CH2OH, —CH2OR4, —CH(OH)CH3, —CH(OR4)CH3, or a group represented by the formula
- wherein
- R4 is a linear or branched C1-C4 alkyl;
- R5 is H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- A-B is a group represented by the formula:
- X is O, —CH2O, —CH2CH2O, —CH(CH3)CH2O, or —CH2CH(CH3)O;
- Z is —CH2CH2O, —CH(CH3)CH2O, or —CH2CH(CH3)O;
- m is an integer of 0 or 1;
- and
- n is an integer of 0-50;
- and salts or hydrates thereof.
A compound represented by the structure of formula II:
- wherein
- the dotted line represents a single or a double bond;
- R5 and R5′ are independently of each other H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- X is O, —CH2O, —CH2CH2O, —CH(CH3)CH2O, or —CH2CH(CH3)O;
- Z is —CH2CH2O, —CH(CH3)CH2O, or CH2CH(CH3)O;
- m is an integer of o or 1;
- and
- n is an integer of 0-50;
- and salts or hydrates thereof.
A compound represented by the structure of formula III:
- wherein
- the dotted line represents a single or a double bond;
- R5 and R5′ are independently of each other H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- Z is —CH2CH2O, —CH(CH3)CH2O, or CH2CH(CH3)O;
- n is an integer of 0-50;
- and salts or hydrates thereof.
A compound represented by the structure of formula IV:
- wherein
- the dotted line represents a single or a double bond;
- R5 and R5′ are independently of each other H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- n is an integer of 0-50;
- and salts or hydrates thereof.
A compound represented by the structure of formula I:
- wherein
- the dotted line represents a single or a double bond;
- R1 and R2 are the same or different, and independently of each other represent —CH2OH, —CH2OR4, —CH(OH)CH3, —CH(OR4)CH3, or a group represented by the formula
- wherein
- R4 is a linear or branched C1-C4 alkyl;
- R5 is H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- A-B is a group represented by the formula:
- X is O, —CH2O, —CH2CH2O, —CH(CH3)CH2O, or —CH2CH(CH3)O;
- Z is —CH2CH2O, —CH(CH3)CH2O or —CH2CH(CH3)O;
- m is 1;
- and
- n is an integer of 1-500;
- and salts or hydrates thereof.
A compound represented by the structure of formula II:
- wherein
- the dotted line represents a single or a double bond;
- R5 and R5′ are independently of each other H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- X is O, —CH2O, —CH2CH2O, —CH(CH3)CH2O, or —CH2CH(CH3)O;
- Z is —CH2CH2O, —CH(CH3)CH2O, or —CH2CH(CH3)O;
- m is 1;
- and
- n is an integer of 1-500;
- and salts or hydrates thereof.
A compound represented by the structure of formula III:
- wherein
- the dotted line represents a single or a double bond;
- R5 and R5′ are independently of each other H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- Z is —CH2CH2O, —CH(CH3)CH2O, or —CH2CH(CH3)O;
- n is an integer of 1-500;
- and salts or hydrates thereof.
A compound represented by the structure of formula IV:
- wherein
- the dotted line represents a single or a double bond;
- R5 and R5′ are independently of each other H, OH or OR6 wherein R6 is a linear or branched C1-C4 alkyl;
- n is an integer of 1-500;
- and salts-or hydrates thereof.
A compound of Formula A:
- wherein R is a polyalkylene glycol polymer having n units, where n is an integer from 1-100.
A compound of Formula B:
- wherein R is a polyalkylene glycol polymer having n units, where n is an integer from 1-100.
A compound of Formula C:
- wherein R is a polyalkylene glycol polymer having n units, where n is an integer from 1-100.
A compound of Formula D:
- wherein R is a polyalkylene glycol polymer having n units, where n is an integer from 1-100.
A compound of Formula E:
- wherein R is a polyalkylene glycol polymer having n units, where n is an integer from 1-100.
A compound of Formula F:
- wherein R is a polyalkylene glycol polymer having n units, where n is an integer from 1-100.
Dependencies are inferred from the claim text.